Image: NASA
What changed
In August 2026 the White House released the National Security Science and Technology Strategy. Its list of critical and emerging technologies for national security includes crewed spaceflight enablers and biotechnologies for space applications.
For the first time, the technology that keeps people alive and working in space sits on the same list as the technologies the United States treats as essential to its security and competitiveness. Crew health has moved from a line item inside space programs to a national priority in its own right.
What the strategy asks for
The strategy directs agencies toward public-private partnerships for early and mid-stage development in areas that include space. It calls for strategic capital structures that bring commercial technology to national security missions.
It frames resilience as graceful degradation: systems that bend under stress and recover, rather than systems that work perfectly until they fail. And it treats Americans' biometric and health data as an asset to protect from foreign adversaries.
Each of these points lands on the same stretch of the pipeline: the early and mid-stage work between a promising prototype and qualified flight hardware, where crew health technology has historically stalled.
Why crew health belongs on the list
Human physiology degrades in microgravity on a timescale with no terrestrial equivalent. Bone mineral density declines at rates measured monthly instead of per decade, and muscle mass and cardiovascular conditioning fall within weeks. After sixty years of human spaceflight, the mechanisms behind most of these changes remain unresolved.
As crews stay longer on commercial stations and prepare for months on the Moon, the limit on what a mission can do is increasingly the body rather than the vehicle. A country that can keep its crews healthy for longer can do more in space, and the record of how bodies change in altered gravity becomes a strategic asset in its own right.
What it means for the Lab
Stellar Amenities Lab is a commercial, national-interest lab built for this priority. We mature crew health and habitation technology from the prototype stage to flight readiness, incubate companies around what we build, and invest in outside teams working on the same problems.
The Lab earns revenue three ways: measurement packages sold to station operators and agencies, training units sold into programs and clinics, and habitat outfitting contracts with NASA and the primes. Licensing the record and the models built on it sits above all three.
In the national interest, we are also building a domestic record of how the human body performs in altered gravity: an intelligence layer that travels with crews and turns every mission into data that helps the next one. Treating that data as something to protect is part of the design from the start.
The national-interest case for investors
Crew health is now a matter of national interest, and that changes who invests in it. Jobs and industry diversification are part of the case, but they are not the core of it. The stronger case rests on three things: resilient domestic capabilities, retaining technical talent and intellectual property, and building an ecosystem that attracts follow-on private investment.
Crew health and habitation technology may also find useful applications on Earth. We separate those possibilities from the applications we can already substantiate, and we lead with the second.
The case also has to match the mandate of whoever is investing. A state asks what capability and economic activity will take root there. A national investor asks how a company reduces a strategic dependency or builds an enduring capability. An agency needs work that supports its directives and fits its procurement and regulatory requirements. Treating these as interchangeable is one of the most common mistakes in raising public capital.
A business that outlasts any one administration
In every lane, the money has to be backed by commercial and technical merit: a product, existing capabilities, or a concrete and independently credible path to them. That comes before any customer commitment.
The strongest position is to be a pathfinder for the newest and highest-priority public objectives, the small set that tends to cut across states, national investors and agencies at once. There are many of those in space and defense right now.
They come with a warning. Work tied too closely to one administration's mandates rarely survives the next one. We pursue these opportunities deliberately, with defined goals and a defined end, and we do not build the Lab's business model on them alone.
That is also why we keep three lanes separate: investment capital, funding for specific R&D objectives, and customer procurement. Each has its own eligibility, restrictions, stakeholders and culture, and our structure and investor story are built around those differences.
The strategy describes the partnership model we have been building toward. If you work on crew health, habitation or the capital that supports them, we would like to talk.